Karnani M. M., Apergis-Schoute J., Adamantidis A., Jensen L. T., de Lecea L., Fugger L., Burdakov D. (2011). Activation of central orexin/hypocretin neurons by dietary amino acids, Neuron, 72(4), 616-29. En savoir plus.

Kauwe J. S., Cruchaga C., Karch C. M., Sadler B., Lee M., Mayo K., Latu W., Su'a M., Fagan A. M., Holtzman D. M., Morris J. C., Breitner J., Alzheimer's Disease Neuroimaging Initiative, Goate A. M. (2011). Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease, PLoS One, 6(2), e15918. En savoir plus.

Landau A. M., Chakravarty M., Clark C. M., Zis A. P., Doudet D. J. (2011). Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates, Neuropsychopharmacology, 36(2), 511-8. En savoir plus.

Lederbogen F., Kirsch P., Haddad L., Streit F., Tost H., Schuch P., Wust S., Pruessner J., Rietschel M., Deuschle M., Meyer-Lindenberg A. (2011). City living and urban upbringing affect neural social stress processing in humans, Nature, 474(7352), 498-501. En savoir plus.

Leduc V., Domenger D., De Beaumont L., Lalonde D., Belanger-Jasmin S., Poirier J. (2011). Function and comorbidities of apolipoprotein e in Alzheimer's disease, Int J Alzheimers Dis, 2011, 974361. En savoir plus.

Leduc V., Legault V., Dea D., Poirier J. (2011). Normalization of gene expression using SYBR green qPCR: A case for paraoxonase 1 and 2 in Alzheimer's disease brains, J Neurosci Methods, 200(1), 14-19. En savoir plus.

Lerch J.P., Yiu A.P., Martinez-Canabal A., Pekar T., Bohbot V., Frankland P.W., Henkelman R.M., Josselyn S.A., Sled J.G. (2011). Maze training in mice induces MRI-detectable brain shape changes specific to the type of learning, Neuroimage, 54(3), 2086-2095. En savoir plus.

Lupien S.J., Parent S., Evans A.C., Tremblay R.E., Zelazo P.D., Corbo V., Pruessner J., Seguin J.R. (2011). Larger amygdala but no change in hippocampal volume in 10-year-old children exposed to maternal depressive symptomatology since birth, Proc Natl Acad Sci U S A, 108(34), 14324-14329. En savoir plus.

Maillet D., Rajah M. (2011). Age-related changes in the three-way correlation between anterior hippocampus volume, whole-brain patterns of encoding activity and subsequent context retrieval, Brain Res, 1420, 68-79. En savoir plus.

Marca R.L., Waldvogel P., Thorn H., Tripod M., Wirtz P.H., Pruessner J., Ehlert U. (2011). Association between Cold Face Test-induced vagal inhibition and cortisol response to acute stress, Psychophysiology, 48(3), 420-429. En savoir plus.

Mareckova K., Weinbrand Z., Chakravarty M., Lawrence C., Aleong R., Leonard G., Perron M., Pike G. B., Richer L., Veillette S., Pausova Z., Paus T. (2011). Testosterone-mediated sex differences in the face shape during adolescence: subjective impressions and objective features, Horm Behav, 60(5), 681-90. En savoir plus.

Massoud F., Desmarais J.E., Gauthier S. (2011). Switching cholinesterase inhibitors in older adults with dementia, Int Psychogeriatr, 23(3), 372-378. En savoir plus.

Matousek R.H., Pruessner J., Dobkin P.L. (2011). Changes in the cortisol awakening response (CAR) following participation in mindfulness-based stress reduction in women who completed treatment for breast cancer, Complement Ther Clin Pract, 17(2), 65-70. En savoir plus.

Mayeux R., Reitz C., Brickman A.M., Haan M.N., Manly J.J., Glymour M.M., Weiss C.C., Yaffe K., Middleton L., Hendrie H.C., Warren L.H., Hayden K.M., Welsh-Bohmer K.A., Breitner J., Morris J.C. (2011). Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1, Alzheimers Dement, 7(1), 15-34. En savoir plus.

McEvoy L. K., Holland D., Hagler D. J., Fennema-Notestine C., Brewer J. B., Dale A. M., Breitner J., Alzheimer's Disease Neuroimaging Initiative (2011). Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis, Radiology, 259(3), 834-43. En savoir plus.

Nicolakakis N., Aboulkassim T., Aliaga A., Tong X.K., Rosa-Neto P., Hamel E. (2011). Intact memory in TGF-beta1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone, J Cereb Blood Flow Metab, 31(1), 200-211. En savoir plus.

Norton M. C., Smith K. R., Ostbye T., Tschanz J. T., Schwartz S., Corcoran C., Breitner J., Steffens D. C., Skoog I., Rabins P. V., Welsh-Bohmer K. A., Cache County Investigators (2011). Early parental death and remarriage of widowed parents as risk factors for Alzheimer disease: the Cache County study, Am J Geriatr Psychiatry, 19(9), 814-24. En savoir plus.

Oishi K., Huang H., Yoshioka T., Ying S. H., Zee D. S., Zilles K., Amunts K., Woods R., Toga A. W., Pike G. B., Rosa-Neto P., Evans A. C., van Zijl P. C., Mazziotta J. C., Mori S. (2011). Superficially located white matter structures commonly seen in the human and the macaque brain with diffusion tensor imaging, Brain Connect, 1(1), 37-47. En savoir plus.

Pasic M.D., Diamandis E.P., McLaurin J., Holtzman D.M., Schmitt-Ulms G., Quirion R. (2011). Alzheimer Disease: Advances in Pathogenesis, Diagnosis, and Therapy, Clin Chem. En savoir plus.

Poirier J., Gauthier S. (2011). La Maladie D’Alzheimer: Le Guide , .